|
Market Closed -
Bombay S.E.
06:03:26 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 1,038.40 INR | +1.43% |
|
+0.31% | -4.72% |
| 08-06 | Jenburkt Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-13 | Jenburkt Pharmaceuticals Limited Announces Address Changes | CI |
| Market Cap | 4.58B 47.93M 41.22M 38.89M 35.43M 66.24M 66.84M 463M 178M 2.32B 180M 176M 7.38B | P/E 2025 |
13.9x | P/E 2026 | 12.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.13B 43.24M 37.19M 35.09M 31.97M 59.76M 60.3M 418M 161M 2.1B 162M 159M 6.66B | EV / Sales 2025 |
2.82x | EV / Sales 2026 | 2.23x |
| Free-Float |
38.82% | Yield 2025 |
1.78% | Yield 2026 | 2.17% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| JENBURPH | Delayed | |
NSE India S.E.
| JENBURPH | Delayed |
| 1 day | +1.43% | ||
| 1 week | +0.31% | ||
| Current month | -1.13% | ||
| 1 month | -2.27% | ||
| 3 months | -10.73% | ||
| 6 months | +4.02% | ||
| Current year | -4.72% |
| 1 week | 1,013.05 |  | 1,056.95 |
| 1 month | 1,008 | | 1,088.95 |
| Current year | 944 | | 1,245 |
| 1 year | 944 | | 1,321 |
| 3 years | 586.9 | | 1,410 |
| 5 years | 452 | | 1,410 |
| 10 years | 243.2 | | 1,410 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2013-10-21 | |
| Director of Finance/CFO | 74 | 2013-09-23 | |
Virendra Zope
ADM | Chief Administrative Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2013-10-21 | |
| Director/Board Member | 74 | 2013-09-06 | |
| Director/Board Member | 63 | 2020-03-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.43% | +0.31% | -7.04% | +48.03% | 47.48M | |
| +0.00% | -3.04% | +49.00% | +88.79% | 1,002B | |
| -0.10% | -4.13% | +51.84% | +64.10% | 644B | |
| +1.11% | -2.50% | +19.87% | +70.22% | 443B | |
| -0.63% | -3.09% | +29.84% | +36.08% | 343B | |
| +0.43% | -14.61% | +11.32% | +26.98% | 262B | |
| +0.93% | -3.19% | -1.31% | +11.96% | 245B | |
| -2.08% | -13.84% | +37.39% | +46.21% | 212B | |
| -0.90% | -5.06% | -18.47% | -58.14% | 199B | |
| -0.65% | -4.14% | +25.78% | +88.16% | 181B | |
| Average | +0.09% | -4.61% | +19.82% | +42.24% | 352.97B | |
| Weighted average by Cap. | +0.04% | -4.24% | +32.03% | +56.06% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.52B 15.87M 13.64M 12.87M 11.73M 21.92M 22.12M 153M 59.01M 769M 59.58M 58.28M 2.44B | 1.69B 17.65M 15.18M 14.32M 13.05M 24.39M 24.61M 171M 65.64M 856M 66.28M 64.83M 2.72B |
| Net income | 321M 3.35M 2.88M 2.72M 2.48M 4.63M 4.68M 32.41M 12.47M 163M 12.59M 12.32M 517M | 347M 3.63M 3.12M 2.95M 2.69M 5.02M 5.07M 35.11M 13.51M 176M 13.64M 13.35M 560M |
| Net Debt | -192M -2.01M -1.73M -1.63M -1.49M -2.78M -2.81M -19.46M -7.49M -97.64M -7.56M -7.4M -310M | -448M -4.69M -4.03M -3.8M -3.47M -6.48M -6.54M -45.31M -17.44M -227M -17.61M -17.22M -722M |
Employees
801
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | ₹1,038.40 | +1.43% | 825 |
| 26-09-09 | ₹1,023.80 | -2.98% | 802 |
| 26-09-08 | ₹1,055.20 | +1.46% | 6 |
| 26-09-07 | ₹1,040.00 | +0.54% | 5 |
| 26-09-04 | ₹1,034.40 | -0.54% | 177 |
- Stock Market
- Stocks
- JENBURPH Stock
Select your edition
All financial news and data tailored to specific country editions
